|
Arvinas, Inc. (ARVN) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Arvinas, Inc. (ARVN) Bundle
Simplify Arvinas, Inc. (ARVN) valuation with this customizable DCF Calculator! Featuring real Arvinas, Inc. (ARVN) financials and adjustable forecast inputs, you can test scenarios and uncover Arvinas, Inc. (ARVN) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.8 | 46.7 | 131.4 | 78.5 | 263.4 | 434.4 | 716.5 | 1,181.8 | 1,949.3 | 3,215.0 |
| Revenue Growth, % | 0 | 114.2 | 181.37 | -40.26 | 235.54 | 64.94 | 64.94 | 64.94 | 64.94 | 64.94 |
| EBITDA | -117.6 | -183.6 | -256.9 | -394.8 | -250.2 | -430.1 | -709.4 | -1,170.0 | -1,929.7 | -3,182.8 |
| EBITDA, % | -539.41 | -393.15 | -195.51 | -502.93 | -94.99 | -99 | -99 | -99 | -99 | -99 |
| Depreciation | 4.0 | 6.0 | 8.2 | 6.7 | .0 | 40.0 | 66.0 | 108.9 | 179.7 | 296.3 |
| Depreciation, % | 18.46 | 12.85 | 6.24 | 8.54 | 0 | 9.22 | 9.22 | 9.22 | 9.22 | 9.22 |
| EBIT | -121.6 | -189.6 | -265.1 | -401.5 | -250.2 | -430.1 | -709.4 | -1,170.0 | -1,929.7 | -3,182.8 |
| EBIT, % | -557.87 | -406 | -201.75 | -511.46 | -94.99 | -99 | -99 | -99 | -99 | -99 |
| Total Cash | 688.5 | 1,502.6 | 1,205.3 | 1,261.0 | 1,039.4 | 434.4 | 716.5 | 1,181.8 | 1,949.3 | 3,215.0 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.0 | 25.7 | 8.0 | 7.2 | 13.7 | 69.6 | 114.8 | 189.3 | 312.2 | 514.9 |
| Account Receivables, % | 4.59 | 55.03 | 6.09 | 9.17 | 5.2 | 16.02 | 16.02 | 16.02 | 16.02 | 16.02 |
| Inventories | .0 | 4.5 | 5.5 | .0 | .0 | 12.0 | 19.8 | 32.7 | 53.9 | 88.9 |
| Inventories, % | 0 | 9.64 | 4.19 | 0 | 0 | 2.76 | 2.76 | 2.76 | 2.76 | 2.76 |
| Accounts Payable | 7.1 | 31.3 | 5.7 | 17.8 | 13.4 | 114.4 | 188.7 | 311.3 | 513.4 | 846.8 |
| Accounts Payable, % | 32.57 | 67.02 | 4.34 | 22.68 | 5.09 | 26.34 | 26.34 | 26.34 | 26.34 | 26.34 |
| Capital Expenditure | -6.4 | -4.7 | -6.8 | -2.9 | -1.8 | -42.7 | -70.5 | -116.3 | -191.8 | -316.3 |
| Capital Expenditure, % | -29.57 | -10.06 | -5.18 | -3.69 | -0.68337 | -9.84 | -9.84 | -9.84 | -9.84 | -9.84 |
| Tax Rate, % | -0.30257 | -0.30257 | -0.30257 | -0.30257 | -0.30257 | -0.30257 | -0.30257 | -0.30257 | -0.30257 | -0.30257 |
| EBITAT | -113.9 | -181.9 | -287.2 | -405.3 | -251.0 | -421.1 | -694.6 | -1,145.6 | -1,889.6 | -3,116.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -110.3 | -185.6 | -294.7 | -383.1 | -263.7 | -390.7 | -677.7 | -1,117.8 | -1,843.7 | -3,040.9 |
| WACC, % | 12.86 | 12.86 | 12.86 | 12.86 | 12.86 | 12.86 | 12.86 | 12.86 | 12.86 | 12.86 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -4,453.1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -3,102 | |||||||||
| Terminal Value | -28,564 | |||||||||
| Present Terminal Value | -15,601 | |||||||||
| Enterprise Value | -20,054 | |||||||||
| Net Debt | -91 | |||||||||
| Equity Value | -19,962 | |||||||||
| Diluted Shares Outstanding, MM | 72 | |||||||||
| Equity Value Per Share | -277.64 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real ARVN financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on Arvinas, Inc.'s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Pre-Loaded Data: Arvinas, Inc.'s historical financial statements and pre-filled forecasts.
- Fully Adjustable Inputs: Modify WACC, tax rates, revenue growth, and EBITDA margins as needed.
- Instant Results: View Arvinas, Inc.'s intrinsic value recalculating in real time.
- Clear Visual Outputs: Dashboard charts illustrate valuation results and essential metrics.
- Built for Accuracy: A professional tool designed for analysts, investors, and finance experts.
How It Works
- 1. Access the Template: Download and open the Excel file containing Arvinas, Inc.'s (ARVN) preloaded data.
- 2. Adjust Assumptions: Modify key parameters such as growth rates, WACC, and capital expenditures.
- 3. View Results Instantly: The DCF model automatically calculates the intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate multiple forecasts to assess various valuation outcomes.
- 5. Present with Confidence: Deliver professional valuation insights to back your decisions.
Why Choose Arvinas, Inc. (ARVN) Calculator?
- Save Time: Skip the hassle of building a model from the ground up – it's ready for immediate use.
- Enhance Accuracy: Dependable financial data and formulas minimize valuation errors.
- Fully Customizable: Adjust the model to align with your specific assumptions and forecasts.
- Simple to Understand: Intuitive charts and outputs facilitate easy analysis of results.
- Endorsed by Professionals: Crafted for experts who prioritize precision and functionality.
Who Should Use This Product?
- Biotech Students: Explore drug development processes and analyze real-world data.
- Researchers: Utilize advanced models for studies related to biopharmaceuticals.
- Investors: Evaluate your investment strategies and assess valuation metrics for Arvinas, Inc. (ARVN).
- Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech firms.
- Healthcare Entrepreneurs: Understand the valuation techniques applied to leading biotech companies like Arvinas, Inc. (ARVN).
What the Template Contains
- Pre-Filled Data: Features Arvinas, Inc.'s historical financials and projections.
- Discounted Cash Flow Model: Customizable DCF valuation model with automated calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on user-defined inputs.
- Key Financial Ratios: Evaluate Arvinas, Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Modify revenue growth, profit margins, and tax rates effortlessly.
- Clear Dashboard: Visuals and tables summarizing essential valuation outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.